Dyslipidemia

Relevant Pages

HIV - Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

• Primary Care Essentials
• Introduction
• Risk Factors and Mechanisms of Dyslipidemia: HIV Infection vs Antiretroviral Therapy
• Screening, Treatment, and Monitoring for Dyslipidemia in HIV-Infected Patients
• Primary Prevention of Dyslipidemia

HIV - The Approach to the HIV-Infected Patient With Specific Symptom Complexes/Common Presentations

• Wasting/Unintentional Weight Loss: Etiology and Diagnostic Approach

HIV - Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

• Clinical Trials of NNRTI-Based vs PI-Based Therapy
• Efavirenz-Based Initial Therapy
• Choosing Among Integrase Inhibitors
• Considerations for Choosing a First-line NNRTI

HIV - Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients

• Additional NRTI-Limiting Switch Options
• Modifying NNRTI-Based Regimens

HIV - Special Considerations in the Management of HIV-Infected Patients From Minority Communities

• Cardiovascular Disease
• Metabolic Syndrome and Diabetes

HIV - Agents Used in Antiretroviral Therapy

• Elvitegravir

HIV - Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

• Treatment Complications

HIV - Special Considerations Related to Aging in HIV-Infected Patients

• Diabetes, Lipodystrophy, and the Metabolic Syndrome

Guidelines

• AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
• ATP III Update 2004: Implications of Recent Clinical Trials for the ATP III Guidelines
• European Guidelines for Treatment of HIV-Infected Adults in Europe—Part III Guidelines for the Prevention and Management of Comorbidities in HIV-Positive Persons
• Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)–Infected Adults Receiving Antiretroviral Therapy
• Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society-USA Panel
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)